Shaping Radionuclides for Nuclear Medicine; Requirements, Production Routes and Emerging Frontiers
Nuclear Future · 09.07.2026 · 22 (4)
DOI: 10.63198/nuclearfuture224913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Future, online erschienen am 10.07.2026. Verfasst von Maria Letizaia Terranova.
Abstract (Originalsprache)
Nuclear medicine is increasingly driven by next-generation tailored radionuclides enabling highly sensitive diagnostic imaging, precision targeted radiotherapy and innovative theranostic strategies This short review discusses the physical and radiochemical requirements of medical radionuclides, highlighting the main diagnostic and therapeutic nuclides currently used or under development. Current limitations in the availability and large-scale production of high-purity radionuclides are examined and discussed in the context of advanced projects and emerging technologies, including high-flux reactors, accelerator-driven systems and novel photon-based facilities.
Zitieren
APA
Terranova, M. L. (2026). Shaping Radionuclides for Nuclear Medicine; Requirements, Production Routes and Emerging Frontiers. Nuclear Future, 22(4). https://doi.org/10.63198/nuclearfuture224913
Vancouver
Terranova ML. Shaping Radionuclides for Nuclear Medicine; Requirements, Production Routes and Emerging Frontiers. Nuclear Future. 2026;22(4). doi:10.63198/nuclearfuture224913
BibTeX
@article{Terranova2026,
author = {Terranova, Maria Letizaia},
title = {Shaping Radionuclides for Nuclear Medicine; Requirements, Production Routes and Emerging Frontiers},
journal = {Nuclear Future},
year = {2026},
volume = {22},
number = {4},
doi = {10.63198/nuclearfuture224913}
}
EUVIMED